Yuya Fujita

12PUBLICATIONS
19CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsRegenerative medicine (incl. stem cells)Predictive and prognostic markersAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 25, 2026
Clinical and immunological outcomes of rituximab-based, mycophenolate mofetil-based and cyclophosphamide-based treatment strategies for systemic lupus erythematosus with active kidney involvement from LOOPS registry.

|May 18, 2026
Impact of trial exclusion criteria on real-world comparative effectiveness of targeted therapies in rheumatoid arthritis: the FIRST Registry.

|Mar 09, 2026
Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs Do Not Arrest Bone Loss in Patients With Rheumatoid Arthritis: A Long-Term Multicenter Observational Study.

Takafumi Aritomi, Koshiro Sonomoto, Shingo Nakayamada

|Feb 05, 2026
Real-world effectiveness of b/tsDMARD switching in low-inflammatory difficult-to-treat rheumatoid arthritis: insights from the FIRST registry.

Hidenori Sakai, Koshiro Sonomoto, Shingo Nakayamada

|Jan 16, 2026
Predicting the progression of difficult-to-treat rheumatoid arthritis by a machine learning scoring system, from the FIRST registry.

Masanobu Ueno, Koshiro Sonomoto, Hiroaki Tanaka

|Feb 26, 2025
Association of peripheral CD8+ T cell activation with disease activity and treatment resistance in systemic lupus erythematosus.

Yuya Fujita, Shingo Nakayamada, Satoshi Kubo

Pageof 2

Frequent Collaborators

11 joint publications

Yoshiya Tanaka

8 joint publications

Satoshi Kubo

7 joint publications

Koshiro Sonomoto

6 joint publications

Ryuichiro Kanda